News - Page 72 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Silo Pharma Announces Stock Repurchase Program

Silo Pharma Announces Stock Repurchase Program

Post published:January 31, 2023
Post category:Press Release

Read more about the article Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs

Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs

Post published:January 30, 2023
Post category:2022 Year in Review

Read more about the article Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Post published:January 28, 2023
Post category:Press Release

Read more about the article Doing Things Differently: Beyond Business as Usual in the Psychedelics Space

Doing Things Differently: Beyond Business as Usual in the Psychedelics Space

Post published:January 27, 2023
Post category:2022 Year in Review

Read more about the article Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining Capitalism and the Purpose-Driven Firm

Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining Capitalism and the Purpose-Driven Firm

Post published:January 27, 2023
Post category:2022 Year in Review

Read more about the article Julia Mande: Consider the Conditions: Growing a Psychedelic Ecosystem

Julia Mande: Consider the Conditions: Growing a Psychedelic Ecosystem

Post published:January 27, 2023
Post category:2022 Year in Review

Read more about the article BetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 Accomplishments

BetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 Accomplishments

Post published:January 27, 2023
Post category:Press Release

Read more about the article Adapting to the Squeeze: Spending Trends, Slimming Pipelines, M&A and Partnerships in 2022

Adapting to the Squeeze: Spending Trends, Slimming Pipelines, M&A and Partnerships in 2022

Post published:January 26, 2023
Post category:2022 Year in Review

Read more about the article Psychedelic Investor Pulse Survey – Q4 2022

Psychedelic Investor Pulse Survey – Q4 2022

Post published:January 26, 2023
Post category:2022 Year in Review

Read more about the article MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023

MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023

Post published:January 25, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.